Page de résultat 12 pour Secteur : Soins de santé Industrie : Biotechnologie Marché boursier - Cotations et cours
Liste de toutes les actions et titres avec cours, capitalisations boursières, ratios P/E et BPA
Tous les pays
- {{country.name}}
- Tous les pays
- États-Unis (1012)
- Australie (58)
- L'Autriche (16)
- Belgique (7)
- Brésil (16)
- Canada (83)
- Chine (92)
- Danemark (6)
- Finlande (4)
- France (41)
- Allemagne (738)
- Hong Kong (46)
- Inde (19)
- Irlande (1)
- Israël (19)
- Italie (4)
- Japon (37)
- Mexique (28)
- Pays-Bas (3)
- Nouvelle-Zélande (1)
- Norvège (14)
- Pologne (9)
- Russie (2)
- Corée du Sud (12)
- Espagne (4)
- Suède (70)
- Suisse (11)
- Taïwan (67)
- Thaïlande (2)
- Turquie (1)
- Royaume-Uni (69)
Tous marchés
- {{item.name}}
- Tous marchés
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KOSDAQ (2)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (289)
- NasdaqGM (143)
- NasdaqGS (218)
- NSE (10)
- NYSE (11)
- NYSE American (18)
- NYSEArca (1)
- NZSE (1)
- Oslo (14)
- OTC Markets EXMKT (119)
- OTC Markets OTCPK (134)
- OTC Markets OTCQB (33)
- OTC Markets OTCQX (7)
- Other OTC (39)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (45)
- Stockholm (70)
- Stuttgart (39)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
Soins de santé (2608)
- {{item.name}}
- Tous secteur
- Soins de santé (2608)
Biotechnologie (2608)
- {{item.name}}
- Toutes les industries
- Biotechnologie (2608)
- Fabricants de médicaments - Général (265)
- Fabricants de médicaments - de spécialité et génériques (1632)
- Plans de soins de santé (57)
- Établissements de soins médicaux (554)
- Détaillants Pharmaceutiques (155)
- Services d'information sur la santé (419)
- Dispositifs médicaux (916)
- Instruments médicaux et des fournitures (501)
- Diagnostiques et Recherche (429)
- Distribution médicale (138)
| Nom Nom | Prix Prix |
24h% 7j Graphique 24h%&7j |
Cap. du marché Cap. du marché | VOL Volume | 24h bas | 24h de haut | Cap. du marché | PER | BPA |
|---|
| Nom Nom | Prix Prix |
24h% 7j Graphique 24h%&7j |
Cap. du marché Cap. du marché | VOL Volume | 24h bas | 24h de haut | Cap. du marché | PER | BPA | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Zealand Pharma A/S ZLDPF | $59.56 — |
0
|
$4.23B — | $100 — | $57.3 — | $57.3 — | $4.23B — | 0 | -$2.72 — | |
| Agios Pharmaceuticals, Inc. AGIO.MX | $1,222 72.36 USD |
0
|
$70.77B 4.19B USD | $0 0 USD | $1,222 72.36 USD | $1,222 72.36 USD | $70.77B 4.19B USD | 5.16 | $236.58 14.01 USD | |
| Mirati Therapeutics, Inc. 26M.F | $53.3 58.26 USD |
0
|
$3.79B 4.14B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.79B 4.14B USD | 0 | $0 0 USD | |
| Mirati Therapeutics MRTX | $58.7 — |
0
|
$4.12B — | $0 — | $0 — | $0 — | $4.12B — | 0 | $0 — | |
| Krystal Biotech, Inc. 4KB.SG | $127.9 139.81 USD |
+5.48
|
$3.7B 4.04B USD | $110 120.24 USD | $125.6 137.3 USD | $128.3 140.25 USD | $3.7B 4.04B USD | 36.02 | $3.55 3.88 USD | |
| Cytokinetics, Incorporated KK3A.F | $30.8 33.67 USD |
+6.21
|
$3.68B 4.02B USD | $150 163.97 USD | $30.8 33.67 USD | $30.8 33.67 USD | $3.68B 4.02B USD | 0 | -$4.45 -4.8 USD | |
| Krystal Biotech, Inc. 4KB.F | $125.4 137.08 USD |
+3.42
|
$3.64B 3.98B USD | $114 124.62 USD | $125.4 137.08 USD | $125.4 137.08 USD | $3.64B 3.98B USD | 36.24 | $3.46 3.78 USD | |
| Asymchem Laboratories (Tianjin) Co., Ltd. 7K90.F | $8.55 9.35 USD |
-0.58
|
$3.63B 3.96B USD | $971 1.06K USD | $8.55 9.35 USD | $8.55 9.35 USD | $3.63B 3.96B USD | 25.14 | $0.34 0.37 USD | |
| BB Biotech AG BB.MI | $65.2 71.27 USD |
0
|
$3.58B 3.91B USD | $10.08K 11.02K USD | $51.6 56.41 USD | $52.9 57.83 USD | $3.58B 3.91B USD | 5.75 | $11.32 12.37 USD | |
| Camurus AB (publ) 7CA.F | $59.85 65.42 USD |
0
|
$3.56B 3.89B USD | $43 47 USD | $59.85 65.42 USD | $59.85 65.42 USD | $3.56B 3.89B USD | 72.10 | $0.83 0.91 USD | |
| Akero Therapeutics, Inc. 0K4.F | $43.31 47.34 USD |
+0.25
|
$3.52B 3.85B USD | $125 136.64 USD | $43.31 47.34 USD | $43.31 47.34 USD | $3.52B 3.85B USD | 0 | -$3.17 -3.4 USD | |
| Genscript Biotech Corporation G51.F | $1.6 1.74 USD |
-4.66
|
$3.51B 3.84B USD | $2.77K 3.03K USD | $1.6 1.74 USD | $1.6 1.74 USD | $3.51B 3.84B USD | 0 | -$0.07 -0.07 USD | |
| CymaBay Therapeutics, Inc. C0I.F | $29.8 32.58 USD |
0
|
$3.43B 3.75B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.43B 3.75B USD | 0 | $0 0 USD | |
| Merus N.V. 2GH.F | $45.2 49.41 USD |
+2.73
|
$3.42B 3.73B USD | $106 115.87 USD | $45.2 49.41 USD | $45.2 49.41 USD | $3.42B 3.73B USD | 0 | -$3.55 -3.8 USD | |
| CymaBay Therapeutics CBAY | $32.48 — |
0
|
$3.73B — | $0 — | $0 — | $0 — | $3.73B — | 0 | $0 — | |
| Zai Lab Limited 1ZL.F | $29.4 32.14 USD |
0
|
$3.4B 3.72B USD | $230 251.42 USD | $29.4 32.14 USD | $29.4 32.14 USD | $3.4B 3.72B USD | 0 | -$2.13 -2.3 USD | |
| Ember Therapeutics EMBT | $0.4 — |
+399852
|
$3.71B — | $3.2K — | $0.0001 — | $0.0001 — | $3.71B — | 0 | $0 — | |
| SpringWorks Therapeutics SWTX | $46.99 — |
0
|
$3.54B — | $0 — | $0 — | $0 — | $3.54B — | 0 | $0 — | |
| Ascentage Pharma Group International 36X.F | $8.65 9.46 USD |
-1.7
|
$3.06B 3.35B USD | $174 190.21 USD | $8.55 9.35 USD | $8.65 9.46 USD | $3.06B 3.35B USD | 0 | -$0.16 -0.1 USD | |
| ACADIA Pharmaceuticals Inc. DR6.F | $18.21 19.9 USD |
+2.33
|
$3.06B 3.34B USD | $100 109.31 USD | $18.21 19.9 USD | $18.21 19.9 USD | $3.06B 3.34B USD | 15.69 | $1.16 1.27 USD | |
| Zealand Pharma A/S 0NZU.IL | $377.2 55.31 USD |
+3.6
|
$22.49B 3.3B USD | $245 35.92 USD | $0 0 USD | $0 0 USD | $22.49B 3.3B USD | 0 | -$15.13 -2.2 USD | |
| Scholar Rock Holding Corporation 2QK.F | $31.2 34.11 USD |
+6.12
|
$2.99B 3.27B USD | $150 163.97 USD | $31.2 34.11 USD | $31.2 34.11 USD | $2.99B 3.27B USD | 0 | -$2.21 -2.4 USD | |
| Galapagos NV GXE.DE | $44.47 48.61 USD |
0
|
$2.93B 3.2B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.93B 3.2B USD | 0 | $0 0 USD | |
| Viking Therapeutics, Inc. 1VT.F | $25.72 28.12 USD |
-1.74
|
$2.89B 3.16B USD | $150 163.97 USD | $25.06 27.39 USD | $26.5 28.96 USD | $2.89B 3.16B USD | 0 | -$0.98 -1.07 USD | |
| Laboratorios Farmaceuticos Rovi, S.A. 41L.F | $55.3 60.45 USD |
+0.91
|
$2.84B 3.1B USD | $80 87.45 USD | $55.3 60.45 USD | $55.3 60.45 USD | $2.84B 3.1B USD | 20.25 | $2.73 2.98 USD | |
| VitaSpring Biomedical VSBC | $1 — |
0
|
$3.1B — | $100 — | $1 — | $1 — | $3.1B — | 0 | $0 — | |
| Syngene International Limited SYNGENE.BO | $634.2 7.67 USD |
-0.49
|
$254.8B 3.08B USD | $7.39K 89.44 USD | $630.25 7.62 USD | $641.85 7.77 USD | $254.8B 3.08B USD | 51.02 | $12.43 0.15 USD | |
| Morphic Holding MORF | $56.99 — |
0
|
$2.86B — | $0 — | $0 — | $0 — | $2.86B — | 0 | $0 — | |
| SK bioscience Co.,Ltd. 302440.KS | $48,300 36.46 USD |
-0.1
|
$3.78T 2.86B USD | $33.72K 25.46 USD | $48,000 36.23 USD | $49,350 37.25 USD | $3.78T 2.86B USD | 0 | $0 0 USD | |
| MorphoSys AG MOR | $18.96 — |
0
|
$2.86B — | $0 — | $0 — | $0 — | $2.86B — | 0 | $0 — | |
| MorphoSys AG MOR2.F | $16.8 18.36 USD |
0
|
$2.61B 2.85B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.61B 2.85B USD | 0 | $0 0 USD | |
| Morphic Holding, Inc. 31Y.F | $50 54.66 USD |
0
|
$2.6B 2.84B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.6B 2.84B USD | 0 | $0 0 USD | |
| MorphoSys AG MOR.VI | $68.15 74.5 USD |
0
|
$2.57B 2.81B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.57B 2.81B USD | 0 | $0 0 USD | |
| MorphoSys AG MOR.F | $67.8 74.11 USD |
0
|
$2.55B 2.79B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.55B 2.79B USD | 0 | $0 0 USD | |
| MorphoSys AG MOR.DE | $67.25 73.51 USD |
0
|
$2.53B 2.77B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.53B 2.77B USD | 0 | $0 0 USD | |
| MorphoSys AG MPSYF | $73.27 — |
0
|
$2.76B — | $0 — | $0 — | $0 — | $2.76B — | 0 | $0 — | |
| Crinetics Pharmaceuticals, Inc. 6Z4.F | $26.8 29.3 USD |
+7.2
|
$2.52B 2.75B USD | $40 43.73 USD | $26.8 29.3 USD | $26.8 29.3 USD | $2.52B 2.75B USD | 0 | -$3.19 -3.4 USD | |
| Ultragenyx Pharmaceutical Inc. UP0.F | $26 28.42 USD |
-22.16
|
$2.46B 2.69B USD | $115 125.71 USD | $26 28.42 USD | $26.4 28.86 USD | $2.46B 2.69B USD | 0 | -$5 -5.4 USD | |
| Everest Medicines Limited 6HN.F | $7.3 7.98 USD |
-2.67
|
$2.37B 2.59B USD | $12 13.12 USD | $7.3 7.98 USD | $7.3 7.98 USD | $2.37B 2.59B USD | 0 | -$0.39 -0.4 USD | |
| MorphoSys AG 0NDV.IL | $67.6 73.9 USD |
0
|
$2.34B 2.56B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.34B 2.56B USD | 0 | $0 0 USD | |
| Bavarian Nordic A/S 0DPB.IL | $183.23 26.86 USD |
+4.57
|
$17.2B 2.52B USD | $469 68.77 USD | $0 0 USD | $0 0 USD | $17.2B 2.52B USD | 13.00 | $14.09 2.07 USD | |
| ABL Bio Inc. 298380.KQ | $68,000 51.33 USD |
0
|
$3.3T 2.49B USD | $158.58K 119.71 USD | $66,800 50.42 USD | $68,600 51.78 USD | $3.3T 2.49B USD | 0 | $0 0 USD | |
| Mirum Pharmaceuticals, Inc. 08D.F | $44.2 48.32 USD |
+5.74
|
$2.28B 2.49B USD | $26 28.42 USD | $44 48.1 USD | $44.2 48.32 USD | $2.28B 2.49B USD | 0 | -$1.36 -1.4 USD | |
| Catalyst Pharmaceuticals, Inc. CN2.F | $18.47 20.18 USD |
+5.48
|
$2.26B 2.47B USD | $52 56.84 USD | $18.47 20.18 USD | $18.47 20.18 USD | $2.26B 2.47B USD | 13.67 | $1.35 1.48 USD | |
| Arrowhead Pharmaceuticals, Inc. HDP1.F | $15.91 17.39 USD |
+0.03
|
$2.21B 2.41B USD | $100 109.31 USD | $15.91 17.39 USD | $15.91 17.39 USD | $2.21B 2.41B USD | 0 | -$0.95 -1.03 USD | |
| ImmunityBio, Inc. 26CA.F | $2.43 2.66 USD |
+2.7
|
$2.15B 2.36B USD | $1K 1.09K USD | $2.35 2.57 USD | $2.44 2.67 USD | $2.15B 2.36B USD | 0 | -$0.47 -0.5 USD | |
| Xenon Pharmaceuticals Inc. XP0.F | $27.6 30.17 USD |
+3.76
|
$2.12B 2.32B USD | $100 109.31 USD | $27.6 30.17 USD | $27.6 30.17 USD | $2.12B 2.32B USD | 0 | -$2.79 -3.04 USD | |
| Galapagos NV G1LP34.SA | $8.39 1.7 USD |
+3.97
|
$11.3B 2.29B USD | $0 0 USD | $0 0 USD | $0 0 USD | $11.3B 2.29B USD | 0 | -$0.86 -0.1 USD | |
| Apellis Pharmaceuticals, Inc. 1JK.F | $15.62 17.08 USD |
+7.35
|
$2.06B 2.25B USD | $680 743.33 USD | $15.62 17.08 USD | $15.62 17.08 USD | $2.06B 2.25B USD | 0 | -$1.49 -1.6 USD | |
| Bavarian Nordic A/S BVNRY | $9.52 — |
+3.37
|
$2.24B — | $670 — | $9.49 — | $9.55 — | $2.24B — | 10.81 | $0.88 — | |
| Bavarian Nordic A/S BV3.DE | $25.3 27.66 USD |
0
|
$1.99B 2.18B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.99B 2.18B USD | 0 | $0 0 USD | |
| Sarepta Therapeutics, Inc. S1RP34.SA | $5.3 1.07 USD |
-1.49
|
$10.59B 2.15B USD | $0 0 USD | $0 0 USD | $0 0 USD | $10.59B 2.15B USD | 0 | -$0.69 -0.1 USD | |
| Ligand Pharmaceuticals Incorporated LGDN.F | $101 110.41 USD |
-0.98
|
$1.95B 2.13B USD | $20 21.86 USD | $101 110.41 USD | $104 113.69 USD | $1.95B 2.13B USD | 0 | -$5.89 -6.4 USD | |
| Bavarian Nordic A/S BVNKF | $26.51 — |
0
|
$2.12B — | $108 — | $26.2 — | $26.2 — | $2.12B — | 10.04 | $2.64 — | |
| Agios Pharmaceuticals, Inc. 8AP.F | $32.8 35.85 USD |
+7.19
|
$1.91B 2.08B USD | $120 131.18 USD | $32.8 35.85 USD | $32.8 35.85 USD | $1.91B 2.08B USD | 3.42 | $9.59 10.48 USD | |
| Bavarian Nordic A/S BV3.F | $24.23 26.49 USD |
+2.67
|
$1.89B 2.06B USD | $113 123.52 USD | $23.48 25.67 USD | $24.23 26.49 USD | $1.89B 2.06B USD | 11.11 | $2.18 2.38 USD | |
| Denali Therapeutics Inc. 4DN.F | $12.68 13.86 USD |
+4.36
|
$1.84B 2.02B USD | $230 251.42 USD | $12.68 13.86 USD | $12.68 13.86 USD | $1.84B 2.02B USD | 0 | -$2.26 -2.4 USD | |
| Denali Therapeutics Inc. 4DN.MU | $12.63 13.8 USD |
+3.1
|
$1.83B 2B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.83B 2B USD | 0 | -$2.28 -2.4 USD | |
| BB Biotech AG BBZA.F | $33.5 36.62 USD |
+2.13
|
$1.83B 2B USD | $886 968.52 USD | $32.7 35.75 USD | $33.5 36.62 USD | $1.83B 2B USD | 0 | -$8.33 -9.1 USD | |
| Veracyte, Inc. 12V.F | $22.8 24.92 USD |
+1.79
|
$1.8B 1.97B USD | $250 273.28 USD | $22.8 24.92 USD | $22.8 24.92 USD | $1.8B 1.97B USD | 63.33 | $0.36 0.39 USD | |
| Vericel Corporation ATQP.F | $35 38.26 USD |
+2.94
|
$1.76B 1.93B USD | $3 3.28 USD | $35 38.26 USD | $35 38.26 USD | $1.76B 1.93B USD | 875.00 | $0.04 0.04 USD | |
| Galapagos GLPGF | $28.63 — |
0
|
$1.91B — | $190 — | $26.2 — | $26.2 — | $1.91B — | 0 | -$3.2 — | |
| Genus GENSF | $26.01 — |
0
|
$1.91B — | $100 — | $26.01 — | $26.01 — | $1.91B — | 0 | -$0.08 — | |
| Galapagos NV GLPG.VI | $25.8 28.2 USD |
+3.61
|
$1.73B 1.9B USD | $0 0 USD | $25.62 28.01 USD | $25.8 28.2 USD | $1.73B 1.9B USD | 0 | -$2.63 -2.8 USD | |
| Galapagos NV GXE.F | $25.9 28.31 USD |
+5.89
|
$1.71B 1.87B USD | $1K 1.09K USD | $25.1 27.44 USD | $25.9 28.31 USD | $1.71B 1.87B USD | 0 | -$2.73 -2.9 USD | |
| IDEAYA Biosciences, Inc. 30J.F | $19.4 21.21 USD |
+6.59
|
$1.71B 1.86B USD | $150 163.97 USD | $19.4 21.21 USD | $19.4 21.21 USD | $1.71B 1.86B USD | 0 | -$3.06 -3.3 USD | |
| Genus plc GBE.F | $25.4 27.77 USD |
+4.1
|
$1.69B 1.84B USD | $1.02K 1.11K USD | $25.4 27.77 USD | $25.4 27.77 USD | $1.69B 1.84B USD | 0 | -$0.07 -0.07 USD | |
| Galapagos NV GXEA.F | $25 27.33 USD |
+2.46
|
$1.68B 1.84B USD | $2 2.19 USD | $25 27.33 USD | $25 27.33 USD | $1.68B 1.84B USD | 0 | -$2.69 -2.9 USD | |
| Amicus Therapeutics, Inc. AM6.F | $5.4 5.9 USD |
+2.86
|
$1.67B 1.83B USD | $1.11K 1.21K USD | $5.4 5.9 USD | $5.4 5.9 USD | $1.67B 1.83B USD | 0 | -$0.07 -0.07 USD | |
| IDEAYA Biosciences, Inc. 30J.SG | $19 20.77 USD |
+7.34
|
$1.67B 1.83B USD | $0 0 USD | $19 20.77 USD | $19 20.77 USD | $1.67B 1.83B USD | 0 | -$3.15 -3.4 USD | |
| Fusion Pharmaceuticals FUSN | $21.41 — |
0
|
$1.82B — | $0 — | $0 — | $0 — | $1.82B — | 0 | $0 — | |
| BioArctic AB (publ) 0RV2.IL | $186.3 18.19 USD |
+2.73
|
$18.64B 1.82B USD | $217 21.18 USD | $0 0 USD | $0 0 USD | $18.64B 1.82B USD | 60.68 | $3.07 0.3 USD | |
| Oxford Nanopore Technologies plc 4R0.F | $1.69 1.85 USD |
+1.44
|
$1.62B 1.77B USD | $15K 16.4K USD | $1.62 1.77 USD | $1.8 1.97 USD | $1.62B 1.77B USD | 0 | -$0.19 -0.2 USD | |
| Ambrx Biopharma AMAM | $28 — |
0
|
$1.77B — | $0 — | $0 — | $0 — | $1.77B — | 0 | $0 — | |
| BioCryst Pharmaceuticals, Inc. BO1.F | $7.6 8.31 USD |
+2.7
|
$1.61B 1.76B USD | $1.1K 1.2K USD | $7.6 8.31 USD | $7.6 8.31 USD | $1.61B 1.76B USD | 0 | -$0.22 -0.2 USD | |
| Sarepta Therapeutics, Inc. AB3A.F | $16.32 17.83 USD |
+1.37
|
$1.6B 1.75B USD | $34 37.17 USD | $16.32 17.83 USD | $16.32 17.83 USD | $1.6B 1.75B USD | 0 | -$2.06 -2.2 USD | |
| Centessa Pharmaceuticals plc 260.F | $11.6 12.68 USD |
+3.57
|
$1.6B 1.75B USD | $0 0 USD | $11.6 12.68 USD | $11.7 12.79 USD | $1.6B 1.75B USD | 0 | -$1.6 -1.7 USD | |
| PeptiDream PPTDF | $13.18 — |
0
|
$1.71B — | $63 — | $11.8 — | $11.8 — | $1.71B — | 16.89 | $0.78 — | |
| Adaptive Biotechnologies Corporation 1HM.F | $9.99 10.92 USD |
+1.26
|
$1.54B 1.68B USD | $10 10.93 USD | $9.99 10.92 USD | $9.99 10.92 USD | $1.54B 1.68B USD | 0 | -$0.81 -0.8 USD | |
| Adaptive Biotechnologies Corporation 1HM.MU | $10.08 11.01 USD |
0
|
$1.53B 1.67B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.53B 1.67B USD | 0 | -$0.81 -0.8 USD | |
| Immunocore Holdings plc 6YG.F | $30.2 33.01 USD |
+3.42
|
$1.52B 1.66B USD | $10 10.93 USD | $28.6 31.26 USD | $30.2 33.01 USD | $1.52B 1.66B USD | 0 | -$0.36 -0.3 USD | |
| Pharma Mar PHMMF | $92.57 — |
0
|
$1.65B — | $100 — | $96.2 — | $96.2 — | $1.65B — | 70.12 | $1.32 — | |
| BB Biotech AG BIOEE.SW | $25.35 28.84 USD |
0
|
$1.45B 1.65B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.45B 1.65B USD | 0 | $0 0 USD | |
| Immunocore Holdings plc 6YG.MU | $29.6 32.36 USD |
+0.68
|
$1.48B 1.62B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.48B 1.62B USD | 0 | -$1.32 -1.4 USD | |
| Pharma Mar, S.A. 0RC6.IL | $81.68 89.28 USD |
+0.31
|
$1.48B 1.61B USD | $1.58K 1.73K USD | $0 0 USD | $0 0 USD | $1.48B 1.61B USD | 73.58 | $1.11 1.21 USD | |
| Ocular Therapeutix, Inc. 0OT.F | $9.14 9.99 USD |
+5.28
|
$1.46B 1.59B USD | $80 87.45 USD | $9.14 9.99 USD | $9.6 10.49 USD | $1.46B 1.59B USD | 0 | -$0.93 -1.01 USD | |
| Jubilant Ingrevia Limited JUBLINGREA.BO | $812.95 9.84 USD |
+1.37
|
$128.55B 1.56B USD | $27.52K 332.96 USD | $796.5 9.64 USD | $820.55 9.93 USD | $128.55B 1.56B USD | 51.97 | $15.64 0.19 USD | |
| BioArctic AB (publ) B9A.F | $16.2 17.71 USD |
-0.25
|
$1.42B 1.55B USD | $500 546.57 USD | $16.2 17.71 USD | $16.2 17.71 USD | $1.42B 1.55B USD | 17.41 | $0.93 1.02 USD | |
| Pharma Mar, S.A. PMRA.F | $81.55 89.15 USD |
+0.49
|
$1.41B 1.54B USD | $50 54.66 USD | $81.55 89.15 USD | $81.55 89.15 USD | $1.41B 1.54B USD | 70.30 | $1.16 1.27 USD | |
| Biotest Aktiengesellschaft BIO3.VI | $29.8 32.58 USD |
0
|
$1.4B 1.53B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.4B 1.53B USD | 0 | $0 0 USD | |
| Biotest Aktiengesellschaft BIO3.F | $30.2 33.01 USD |
+1.34
|
$1.4B 1.53B USD | $600 655.88 USD | $29.6 32.36 USD | $30.2 33.01 USD | $1.4B 1.53B USD | 0 | -$0.63 -0.6 USD | |
| Biotest Aktiengesellschaft BIO.F | $42.2 46.13 USD |
0
|
$1.4B 1.53B USD | $30 32.79 USD | $42.2 46.13 USD | $42.2 46.13 USD | $1.4B 1.53B USD | 0 | -$0.63 -0.6 USD | |
| Biotest Aktiengesellschaft BIO.DE | $42.2 46.13 USD |
-0.94
|
$1.4B 1.53B USD | $175 191.3 USD | $42.2 46.13 USD | $43 47 USD | $1.4B 1.53B USD | 0 | -$0.63 -0.6 USD | |
| PeptiDream Inc. 4587.T | $1,689 11.4 USD |
+7.17
|
$218.98B 1.48B USD | $994.1K 6.71K USD | $1,614 10.89 USD | $1,708 11.53 USD | $218.98B 1.48B USD | 14.78 | $114.22 0.77 USD | |
| Vir Biotechnology, Inc. VIR.MX | $172 10.18 USD |
0
|
$23.78B 1.41B USD | $0 0 USD | $172 10.18 USD | $172 10.18 USD | $23.78B 1.41B USD | 0 | -$78.1 -4.6 USD | |
| Lexicon Pharmaceuticals, Inc. LX31.MU | $3.53 3.86 USD |
0
|
$1.28B 1.39B USD | $250 273.28 USD | $3.53 3.86 USD | $3.53 3.86 USD | $1.28B 1.39B USD | 0 | -$0.55 -0.6 USD | |
| Shanghai Haohai Biological Technology Co., Ltd. 5HB.F | $2.84 3.1 USD |
+0.71
|
$1.27B 1.39B USD | $4 4.37 USD | $2.84 3.1 USD | $2.84 3.1 USD | $1.27B 1.39B USD | 13.52 | $0.21 0.23 USD | |
| Celldex Therapeutics, Inc. TCE2.F | $18.9 20.66 USD |
+5
|
$1.26B 1.38B USD | $36 39.35 USD | $18.9 20.66 USD | $18.9 20.66 USD | $1.26B 1.38B USD | 0 | -$2.27 -2.4 USD | |
| POINT Biopharma Global PNT | $12.5 — |
0
|
$1.33B — | $0 — | $0 — | $0 — | $1.33B — | 0 | $0 — | |
| Mesoblast MEOBF | $0.9699 — |
0
|
$1.31B — | $1K — | $0.9699 — | $0.9699 — | $1.31B — | 0 | -$0.06 — | |
|
Aucune action favorite
Vous n'avez pas encore d'actions favorites, veuillez l'ajouter aux favoris pour la voir ici |
||||||||||